Shanghai Xiao Fang Pharmaceutical Co.,Ltd. (SHA:603207)

China flag China · Delayed Price · Currency is CNY
29.77
-0.04 (-0.13%)
At close: Feb 27, 2026
Market Cap4.79B +11.6%
Revenue (ttm)504.59M +6.9%
Net Income213.50M +8.5%
EPS1.33 -16.2%
Shares Out160.82M
PE Ratio22.42
Forward PEn/a
Dividend1.40 (4.70%)
Ex-Dividend DateOct 20, 2025
Volume623,339
Average Volume1,236,265
Open29.84
Previous Close29.81
Day's Range29.67 - 29.92
52-Week Range22.66 - 39.47
Betan/a
RSI45.93
Earnings DateApr 22, 2026

About SHA:603207

Shanghai Xiao Fang Pharmaceutical Co.,Ltd. produces and sells medicines in China. It offers medicines in the areas of gastroenterology, dermatology, orthopedics and traumatology, five senses, and disinfection. Shanghai Xiao Fang Pharmaceutical Co.,Ltd. was founded in 1993 and is based in Shanghai, China. [Read more]

Sector Healthcare
Founded 1993
Employees 404
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603207
Full Company Profile

Financial Performance

In 2024, SHA:603207's revenue was 474.58 million, an increase of 0.57% compared to the previous year's 471.87 million. Earnings were 205.27 million, an increase of 0.81%.

Financial Statements